Sunvozertinib Shows Promising First-Line PFS Benefit in EGFR Exon 20 Insertion NSCLC
Medicare delays BALANCE Part D rollout, extending GLP-1 Bridge access through 2027, balancing obesity treatment access for seniors with payer concerns over cost, utilization, and sustainability.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.